Rezultati

eNauka >  Rezultati >  POD1UM-304: Phase III study of retifanlimab plus platinum-based chemotherapy (Chemo) as first-line (1L) therapy for nonsquamous or squamous metastatic nonesmall cell lung cancer (mNSCLC)
Title: POD1UM-304: Phase III study of retifanlimab plus platinum-based chemotherapy (Chemo) as first-line (1L) therapy for nonsquamous or squamous metastatic nonesmall cell lung cancer (mNSCLC)
Authors: Lu, S; Vynnychenko, O; Kulyaba, Y; Kuchava, V; Ibrahim, A; Moiseenko, FV; Arslan, C; Nguyen, DT; Zhang, M; Petrovic, MD;
Cicin, I; Bibichadze, K; Cil, T; Cornfeld, M; Tian, C; Munteanu, M; Sette, CVDM; Bondarenko, I;
Issue Date: 2024
Publication: ANNALS OF ONCOLOGY
ISSN: 0923-7534 Annals of Oncology Search Idenfier
Type: Conference Paper
Collation: vol. 35 str. S1633-S1634
DOI: 10.1016/j.annonc.2024.10.660
WoS-ID: 001401985200416
URI: https://enauka.gov.rs/handle/123456789/970649
Project: Incyte Corporation, Wilmington, DE, USA
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Alt metrika
Dimensions
Unpaywall

Google ScholarTM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.